Meet Team Norway at EANM 2026
17 October 2026 - 21 October 2026
Exhibition
Norway is investing heavily in nuclear medicine and radiopharmaceuticals — and it shows. Meet the companies shaping Europe’s next generation of diagnostics and targeted therapies at EANM 2026.
EANM is Europe’s premier congress for nuclear medicine and molecular imaging, bringing together clinicians, researchers and industry leaders from across the globe. It’s a prime arena to highlight Norway’s accelerating capabilities in imaging, precision diagnostics and therapy innovation.
More information about Team Norway activities will follow.
Reach out if you’re exploring collaboration in nuclear medicine or radiopharma.
Contact us
Tone Varslot Stave
Head of national export initiative on health and life science, Innovation Norway
Important conditions
Companies must adhere to standards for responsible business conduct, including Environmental, Social, and Governance (ESG) criteria.
Participants are expected to operate in accordance with the UN Guiding Principles on Business and Human Rights and the OECD Guidelines for Multinational Enterprises on Responsible Business Conduct. This entails conducting business responsibly, respecting human rights, ensuring decent working conditions, safeguarding environmental considerations, and actively preventing corruption.
Companies must carry out their own due diligence assessments (risk assessments) to identify, prevent, and mitigate potential adverse impacts.